Please login to the form below

Not currently logged in
Email:
Password:

ALS

This page shows the latest ALS news and features for those working in and with pharma, biotech and healthcare.

Setback for Takeda as Ninlaro flunks amyloidosis trial

Setback for Takeda as Ninlaro flunks amyloidosis trial

AL is a rare disease that leads to the widespread build-up of amyloid deposits in tissues and organs outside the central nervous system, and results from abnormal plasma cells in ... Takeda had hoped that Ninlaro – an orally-active proteasome inhibitor

Latest news

More from news
Approximately 11 fully matching, plus 90 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 17 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 36 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics